# GABPB2

## Overview
GABPB2 is a gene that encodes the GA binding protein transcription factor subunit beta 2 (GABPβ2), a component of the GA-binding protein (GABP) complex, which is part of the ETS family of transcription factors. The GABP complex functions as a heterodimer, with GABPα binding to DNA and GABPβ2 playing a crucial role in transactivating target genes. GABPβ2 is characterized by its ankyrin repeats and carboxy-terminal dimerization domain, which facilitate interactions with GABPα and other protein subunits, forming a heterotetrameric complex essential for DNA binding and transcriptional regulation (de1994Molecular). GABPB2 is involved in various cellular processes, including mitochondrial biogenesis, cellular energy metabolism, and the cell cycle, and plays a role in modulating immune responses and osteogenic differentiation (Xu2014GABPβ2; Rosmarin2004GAbinding). While its clinical significance in cancer and other diseases is still being explored, GABPB2's involvement in transcriptional regulation highlights its potential impact on cellular function and disease (Yuan2020TERT).

## Structure
The GABPB2 gene encodes the GABPβ2-1 protein, a component of the GA binding protein transcription factor complex. The primary structure of GABPβ2-1 includes ankyrin repeats and a carboxy-terminal dimerization domain. The ankyrin repeats, located at residues 1-130, are crucial for interaction with GABPα and DNA binding, particularly to the CGGAAR motif (de1994Molecular). The carboxy-terminal dimerization domain, spanning residues 317-366, facilitates dimerization through amphipathic α-helical domains, allowing the protein to form both homodimers and heterodimers with GABPβ1-1 (de1994Molecular).

The secondary structure of GABPβ2-1 is characterized by coiled-coil α-helices in the dimerization domain, which are free of α-helix destabilizing residues and can adopt a stable helical structure, as confirmed by circular dichroism spectroscopy (de1994Molecular). This domain is essential for the protein's quaternary structure, enabling the formation of a heterotetrameric complex with GABPα (de1994Molecular).

GABPB2 is part of the ETS family of transcription factors, which are known for their conserved winged helix-turn-helix DNA-binding domain. The protein may undergo alternative splicing, resulting in structural heterogeneity that affects its interactions with transcriptional cofactors (Zhu2014GA).

## Function
GABPB2 encodes a subunit of the GA-binding protein (GABP) transcription factor, which is part of the ETS family of transcription factors. GABP functions as a heterodimer composed of GABPα and GABPβ subunits, with GABPα binding to DNA and GABPβ, including the GABPβ2 isoform, transactivating target genes (Jing2008GABPβ2). GABPB2 is involved in various cellular processes, including mitochondrial biogenesis, cellular energy metabolism, and the cell cycle. It regulates genes crucial for these processes by binding to specific DNA sequences (Rosmarin2004GAbinding).

In lymphocytes, GABPB2 is not essential for normal T and B cell development, but it plays a role in modulating B cell proliferation and immune responses. GABPB2-deficient B cells exhibit increased proliferation in response to B cell receptor stimulation and enhanced antibody production when exposed to T-dependent antigens (Jing2008GABPβ2). The protein is active in the nucleus, where it forms complexes with other subunits to exert its regulatory functions (de1994Molecular).

GABPB2 also plays a role in osteogenic differentiation. In human osteoblast-like Saos-2 cells, GABPB2 expression peaks during early osteogenic differentiation, suggesting a regulatory role in this process, potentially in synergy with the bone-specific transcription factor Runx2 (Xu2014GABPβ2).

## Clinical Significance
The GABPB2 gene, encoding a subunit of the GA binding protein transcription factor, plays a role in various cancers through its involvement in transcriptional regulation. In cancers such as hepatocellular carcinoma (HCC), melanoma, and glioblastoma, there is a noted gain or amplification of the GABPB2 gene. Despite this, the mutant TERT promoter in these cancers preferentially recruits the GABPA-GABPB1 complex rather than GABPA-GABPB2, suggesting a nuanced role for GABPB2 in tumorigenesis (Yuan2020TERT).

The clinical significance of GABPB2 is not fully understood, but its overexpression in cancers with TERT promoter mutations indicates a potential role in cancer development. The GABPB2 gene's involvement in forming the GABP complex suggests its participation in transcriptional regulation, although specific disease associations related to alterations in GABPB2 expression are not directly addressed (de1994Molecular).

In the context of hematopoietic stem/progenitor cells, GABPB2, along with other GABP subunits, is involved in maintaining HSC homeostasis and functionality. However, mice lacking GABPB2 subunits remain viable, indicating possible redundancy or compensation by other transcription factors (Yu2011GABP). Further research is needed to elucidate the specific contributions of GABPB2 in these contexts.

## Interactions
GABPB2, a subunit of the GA-binding protein (GABP) transcription factor complex, is involved in several protein-protein interactions essential for its function. GABPB2 interacts with GABPα to form a heterodimer, which is crucial for DNA binding and transcriptional activation. This interaction is mediated by the ankyrin repeats in the N-terminus of GABPB2, which facilitate protein-protein interactions with GABPα (Batchelor1998The; Jing2008GABPβ2). The C-terminus of GABPB2 can mediate the formation of homodimers and heterodimers with other GABPβ isoforms, such as GABPB1L, through a leucine zipper-like structure (Jing2008GABPβ2; de1994Molecular).

GABPB2 does not directly bind DNA but enhances the DNA-binding affinity of GABPα, allowing the GABP complex to interact with specific DNA sequences containing a core GGA motif (Batchelor1998The). The GABPB2 protein can also form a heterotetrameric complex with GABPα, which binds to DNA sequences with tandem repeats of the GGA motif, increasing the avidity for the target site (Batchelor1998The). These interactions highlight the role of GABPB2 in modulating the transcriptional activity of the GABP complex.


## References


[1. (Yuan2020TERT) Xiaotian Yuan, Mingkai Dai, and Dawei Xu. Tert promoter mutations and gabp transcription factors in carcinogenesis: more foes than friends. Cancer Letters, 493:1–9, November 2020. URL: http://dx.doi.org/10.1016/j.canlet.2020.07.003, doi:10.1016/j.canlet.2020.07.003. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2020.07.003)

[2. (Batchelor1998The) Adrian H. Batchelor, Derek E. Piper, Fabienne Charles de la Brousse, Steven L. McKnight, and Cynthia Wolberger. The structure of gabpα/β: an ets domain- ankyrin repeat heterodimer bound to dna. Science, 279(5353):1037–1041, February 1998. URL: http://dx.doi.org/10.1126/science.279.5353.1037, doi:10.1126/science.279.5353.1037. This article has 236 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.279.5353.1037)

[3. (Xu2014GABPβ2) Xiaoyuan Xu, Jianjun Xiong, Tao Wang, Meirong Zheng, Ping Wu, Xinping Wang, He Jiang, Benyi Yi, Bin Lang, and Weidong Li. Gabpβ2 expression during osteogenic differentiation from human osteoblast-like saos-2 cells. Folia Histochemica et Cytobiologica, 52(3):225–231, October 2014. URL: http://dx.doi.org/10.5603/fhc.2014.0026, doi:10.5603/fhc.2014.0026. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.5603/fhc.2014.0026)

[4. (Zhu2014GA) Wan Zhu, Gayathri Swaminathan, and Edward D Plowey. Ga binding protein augments autophagy via transcriptional activation ofbecn1-pik3c3complex genes. Autophagy, 10(9):1622–1636, July 2014. URL: http://dx.doi.org/10.4161/auto.29454, doi:10.4161/auto.29454. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.4161/auto.29454)

[5. (Rosmarin2004GAbinding) A Rosmarin. Ga-binding protein transcription factor: a review of gabp as an integrator of intracellular signaling and protein–protein interactions. Blood Cells, Molecules, and Diseases, 32(1):143–154, February 2004. URL: http://dx.doi.org/10.1016/j.bcmd.2003.09.005, doi:10.1016/j.bcmd.2003.09.005. This article has 165 citations.](https://doi.org/10.1016/j.bcmd.2003.09.005)

[6. (de1994Molecular) F C de la Brousse, E H Birkenmeier, D S King, L B Rowe, and S L McKnight. Molecular and genetic characterization of gabp beta. Genes &amp; Development, 8(15):1853–1865, August 1994. URL: http://dx.doi.org/10.1101/gad.8.15.1853, doi:10.1101/gad.8.15.1853. This article has 70 citations.](https://doi.org/10.1101/gad.8.15.1853)

[7. (Jing2008GABPβ2) Xuefang Jing, Dong-Mei Zhao, Thomas J. Waldschmidt, and Hai-Hui Xue. Gabpβ2 is dispensible for normal lymphocyte development but moderately affects b cell responses. Journal of Biological Chemistry, 283(36):24326–24333, September 2008. URL: http://dx.doi.org/10.1074/jbc.m804487200, doi:10.1074/jbc.m804487200. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m804487200)

[8. (Yu2011GABP) Shuyang Yu, Kairong Cui, Raja Jothi, Dong-Mei Zhao, Xuefang Jing, Keji Zhao, and Hai-Hui Xue. Gabp controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood, 117(7):2166–2178, February 2011. URL: http://dx.doi.org/10.1182/blood-2010-09-306563, doi:10.1182/blood-2010-09-306563. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2010-09-306563)